Hoa Le Thi
Hoa Le Thi has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Tran Thai Hoa
Department of Chemistry, University of Sciences, Hue University, 77 Nguyen Hue Street, Hue City 530000, Vietnam
4 shared publications - Le Thi Thanh Nhi
Center for Advanced Chemistry, Institute of Research and Development, Duy Tan University, 03 Quang Trung, Da Nang 550000, Vietnam and Faculty of Natural Sciences, Duy Tan University, 03 Quang Trung, Da Nang 550000, Vietnam
3 shared publications - Dinh Quang Khieu
Hue University
2 shared publications - Nguyen Duc Cuong
Faculty of Chemistry, Hue University of Education
2 shared publications - Pham Van Tat
Institute of Pharmaceutical Education and Research
2 shared publications Trinh Ngoc Dat
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Beilstein Institut in Beilstein Journal of Nanotechnology
- Vol. 17 (1) , 1396-1409
A CuO/ZnFe 2 O 4 heterostructure as an efficient catalyst for NaBH 4 -assisted reduction of chloramphenicol
In this study, a CuO/ZnFe 2 O 4 heterostructure in the form of a flower, consisting of rod-like surface features associated with CuO on ZnFe 2 O 4 microspheres, was successfully synthesized and evaluated for its catalytic reduction of chloramphenicol (CAP) in the presence of NaBH 4 . Structural and morphological analysis confirmed the successful formation of the heterostructure with enhanced contact between ZnFe 2 O 4 and CuO. Compared to pure ZnFe 2 O 4 , the CuO/ZnFe 2 O 4 catalyst exhibited significantly improved catalytic activity for CAP reduction. Reaction conditions strongly influenced reduction efficiency, with optimal performance at pH 6, a catalyst dosage of 2.5 g·L −1 , and a short reaction time of 20 min. The enhanced catalytic performance under mild, environmentally friendly conditions highlights CuO’s crucial role in promoting surface electron transfer and facilitating reduction. Kinetic analysis at room temperature indicated a change in apparent kinetic behavior during the reaction, with pseudo-first-order behavior in the initial stage and a tendency toward zeroth-order behavior at later times. This evolution is consistent with the involvement of surface-mediated catalytic processes. Overall, the CuO/ZnFe 2 O 4 heterostructure shows significant potential as an efficient catalyst for rapid CAP reduction under near-neutral conditions, offering a promising strategy for wastewater treatment.
- 16 October 2026
- Published by Beilstein Institut in Beilstein Journal of Nanotechnology
- Vol. 17 (1) , 1396-1409
Open AccessA CuO/ZnFe 2 O 4 heterostructure as an efficient catalyst for NaBH 4 -assisted reduction of chloramphenicol
In this study, a CuO/ZnFe 2 O 4 heterostructure in the form of a flower, consisting of rod-like surface features associated with CuO on ZnFe 2 O 4 microspheres, was successfully synthesized and evaluated for its catalytic reduction of chloramphenicol (CAP) in the presence of NaBH 4 . Structural and morphological analysis confirmed the successful formation of the heterostructure with enhanced contact between ZnFe 2 O 4 and CuO. Compared to pure ZnFe 2 O 4 , the CuO/ZnFe 2 O 4 catalyst exhibited significantly improved catalytic activity for CAP reduction. Reaction conditions strongly influenced reduction efficiency, with optimal performance at pH 6, a catalyst dosage of 2.5 g·L −1 , and a short reaction time of 20 min. The enhanced catalytic performance under mild, environmentally friendly conditions highlights CuO’s crucial role in promoting surface electron transfer and facilitating reduction. Kinetic analysis at room temperature indicated a change in apparent kinetic behavior during the reaction, with pseudo-first-order behavior in the initial stage and a tendency toward zeroth-order behavior at later times. This evolution is consistent with the involvement of surface-mediated catalytic processes. Overall, the CuO/ZnFe 2 O 4 heterostructure shows significant potential as an efficient catalyst for rapid CAP reduction under near-neutral conditions, offering a promising strategy for wastewater treatment.
- Open Access
- 26 June 2026
- Published by Beilstein Institut in Beilstein Archives
CuO/ZnFe 2 O 4 heterostructure as efficient catalyst for NaBH 4 - assisted reduction of Chloramphenicol
In this study, CuO/ZnFe 2 O 4 heterostructure in the form of flower, consisting of CuO nanorods anchored on ZnFe 2 O 4 microspheres, was successfully synthesized and evaluated for its catalytic reduction of chloramphenicol (CAP) in the presence of NaBH 4 . Structural and morphological analysis confirmed the successful formation of the heterostructure with enhanced contact between ZnFe 2 O 4 and CuO. Compared to pure ZnFe 2 O 4 , the CuO/ZnFe 2 O 4 catalyst exhibited significantly improved catalytic activity for CAP reduction. The reduction efficiency was strongly influenced by reaction conditions, with optimal performance achieved at pH 6, a catalyst dosage of 2.5 g/L, and a short reaction time of 20 minutes. The enhanced catalytic performance under mild, environmentally friendly conditions highlights the crucial role of CuO in promoting surface electron transfer and facilitating reduction. Kinetic analysis at room temperature revealed a shift from pseudo-first-order to zero-order kinetics throughout the reaction, suggesting surface-mediated catalysis. This evolution indicates that decatalysis is primarily governed by a surface-mediated Langmuir–Hinshelwood mechanism. Overall, the CuO/ZnFe 2 O 4 heterostructure shows significant potential as an efficient catalyst for rapid CAP reduction under neutral conditions, offering a promising strategy for wastewater treatment.
- 26 June 2026
- Published by Beilstein Institut in Beilstein Archives
Open AccessCuO/ZnFe 2 O 4 heterostructure as efficient catalyst for NaBH 4 - assisted reduction of Chloramphenicol
In this study, CuO/ZnFe 2 O 4 heterostructure in the form of flower, consisting of CuO nanorods anchored on ZnFe 2 O 4 microspheres, was successfully synthesized and evaluated for its catalytic reduction of chloramphenicol (CAP) in the presence of NaBH 4 . Structural and morphological analysis confirmed the successful formation of the heterostructure with enhanced contact between ZnFe 2 O 4 and CuO. Compared to pure ZnFe 2 O 4 , the CuO/ZnFe 2 O 4 catalyst exhibited significantly improved catalytic activity for CAP reduction. The reduction efficiency was strongly influenced by reaction conditions, with optimal performance achieved at pH 6, a catalyst dosage of 2.5 g/L, and a short reaction time of 20 minutes. The enhanced catalytic performance under mild, environmentally friendly conditions highlights the crucial role of CuO in promoting surface electron transfer and facilitating reduction. Kinetic analysis at room temperature revealed a shift from pseudo-first-order to zero-order kinetics throughout the reaction, suggesting surface-mediated catalysis. This evolution indicates that decatalysis is primarily governed by a surface-mediated Langmuir–Hinshelwood mechanism. Overall, the CuO/ZnFe 2 O 4 heterostructure shows significant potential as an efficient catalyst for rapid CAP reduction under neutral conditions, offering a promising strategy for wastewater treatment.
- Open Access
- 22 June 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (26) , 39390-39416
Development of Novel Inhibitors for Alzheimer's Disease from Erythrina variegata L. Extract-Derived Clusters Using Molecular Docking, QSAR Modeling, Quantum Chemical Calculations, and Molecular Dynamics Simulations
The objective of this investigation is to identify and enhance compounds from the medicinal plant Erythrina variegata L. that possess potential inhibitory activity against acetylcholinesterase (AChE). Consequently, this investigation will contribute to the pursuit of supportive therapeutic agents for Alzheimer’s disease. The initial research matrix was composed of nanocluster materials that were derived from the crude extract. The identification of 13 compounds was achieved by utilizing an ultraperformance liquid chromatography system in conjunction with quadrupole time-of-flight mass spectrometry for structural elucidation. Compound VN62 was chosen due to its favorable binding energy (ES = −8.038 kcal/mol) and RMSD = 1.388 Å, as evidenced by molecular docking simulations and analytical results with the AChE protein (PDB ID: 1EVE). The pIC50 values were predicted using reliable QSAR models, such as QSARGA‑MLR, QSARGA‑ANN, and QSARKPLS‑LF, which were constructed on this basis. Five novel derivatives (VN62N1–VN62N5) were designed from VN62, subsequently semisynthesized, and structurally confirmed using spectroscopic methods, guided by QSAR and docking results. The AChE inhibitory activity was assessed in vitro, and VN62 demonstrated an IC50 of 1.34 μg/mL (pIC50 = 5.498). Conversely, the newly designed derivatives demonstrated a trend toward enhanced activity. Furthermore, a multicriteria evaluation model integrating QSAR, docking, ADMET, and quantum descriptors identified VN62N4 as the top-ranked candidate overall. Molecular dynamics simulations over 400 ns confirmed the structural stability of the VN62N4–AChE complex, as evidenced by stable RMSD, low RMSF in active-site residues, and persistent hydrogen bonding and hydrophobic interactions. The findings verify the efficacy of a comprehensive, multimethod in silico screening strategy in directing the development of AChE inhibitors.
- 22 June 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (26) , 39390-39416
Open AccessDevelopment of Novel Inhibitors for Alzheimer's Disease from Erythrina variegata L. Extract-Derived Clusters Using Molecular Docking, QSAR Modeling, Quantum Chemical Calculations, and Molecular Dynamics Simulations
The objective of this investigation is to identify and enhance compounds from the medicinal plant Erythrina variegata L. that possess potential inhibitory activity against acetylcholinesterase (AChE). Consequently, this investigation will contribute to the pursuit of supportive therapeutic agents for Alzheimer’s disease. The initial research matrix was composed of nanocluster materials that were derived from the crude extract. The identification of 13 compounds was achieved by utilizing an ultraperformance liquid chromatography system in conjunction with quadrupole time-of-flight mass spectrometry for structural elucidation. Compound VN62 was chosen due to its favorable binding energy (ES = −8.038 kcal/mol) and RMSD = 1.388 Å, as evidenced by molecular docking simulations and analytical results with the AChE protein (PDB ID: 1EVE). The pIC50 values were predicted using reliable QSAR models, such as QSARGA‑MLR, QSARGA‑ANN, and QSARKPLS‑LF, which were constructed on this basis. Five novel derivatives (VN62N1–VN62N5) were designed from VN62, subsequently semisynthesized, and structurally confirmed using spectroscopic methods, guided by QSAR and docking results. The AChE inhibitory activity was assessed in vitro, and VN62 demonstrated an IC50 of 1.34 μg/mL (pIC50 = 5.498). Conversely, the newly designed derivatives demonstrated a trend toward enhanced activity. Furthermore, a multicriteria evaluation model integrating QSAR, docking, ADMET, and quantum descriptors identified VN62N4 as the top-ranked candidate overall. Molecular dynamics simulations over 400 ns confirmed the structural stability of the VN62N4–AChE complex, as evidenced by stable RMSD, low RMSF in active-site residues, and persistent hydrogen bonding and hydrophobic interactions. The findings verify the efficacy of a comprehensive, multimethod in silico screening strategy in directing the development of AChE inhibitors.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nanotechnology
- Vol. 2026 (1)
Green Synthesized Ag–Cu/Carbon Quantum Dots as Synergistic Peroxidase‐Mimicking Nanoenzymes for Colorimetric Glucose Detection
Peroxidase‐mimicking Ag–Cu/CQDs nanocomposites were successfully synthesized via a green approach, in which CQDs acted as both reducing and stabilizing agents for the simultaneous formation of AgNPs and CuNPs. The resulting nanozyme system exhibited a synergistic catalytic effect, arising from enhanced electronic interactions between Ag and Cu by CQDs, thereby increasing peroxidase‐like activity. This activity of Ag–Cu/CQDs was demonstrated through the catalytic oxidation of colorless 3,3′,5,5′‐tetramethylbenzidine (TMB) substrate to blue TMB ox via the generation of hydroxyl radicals (OH • ) in the presence of H 2 O 2 . Based on this principle, a colorimetric glucose (GL) detection method was developed by coupling glucose oxidase (GOx) with Ag–Cu/CQDs as nanozyme catalysts. The reaction mechanism consists of two main steps: (i) the oxidation of GL by GOx generates H 2 O 2 , and (ii) Ag–Cu/CQDs catalyze the decomposition of H 2 O 2 , generating OH • , and then oxidize TMB to blue TMB ox . The established system exhibited excellent catalytic performance for detecting H 2 O 2 and GL, achieving detection limits of 0.14 and 0.06 mM, respectively, which are lower than those reported for some nanozyme‐based GL sensors. Furthermore, the developed assay successfully analyzed human urine samples, yielding recoveries ranging from 100.0% to 104.3%. Compared with natural peroxidase enzymes, Ag–Cu/CQDs have significant advantages, including simple synthesis, high stability, and cost‐effectiveness, making them promising candidates for biosensor applications.
- 1 January 2026
- Published by Wiley in Journal of Nanotechnology
- Vol. 2026 (1)
Open AccessGreen Synthesized Ag–Cu/Carbon Quantum Dots as Synergistic Peroxidase‐Mimicking Nanoenzymes for Colorimetric Glucose Detection
Peroxidase‐mimicking Ag–Cu/CQDs nanocomposites were successfully synthesized via a green approach, in which CQDs acted as both reducing and stabilizing agents for the simultaneous formation of AgNPs and CuNPs. The resulting nanozyme system exhibited a synergistic catalytic effect, arising from enhanced electronic interactions between Ag and Cu by CQDs, thereby increasing peroxidase‐like activity. This activity of Ag–Cu/CQDs was demonstrated through the catalytic oxidation of colorless 3,3′,5,5′‐tetramethylbenzidine (TMB) substrate to blue TMB ox via the generation of hydroxyl radicals (OH • ) in the presence of H 2 O 2 . Based on this principle, a colorimetric glucose (GL) detection method was developed by coupling glucose oxidase (GOx) with Ag–Cu/CQDs as nanozyme catalysts. The reaction mechanism consists of two main steps: (i) the oxidation of GL by GOx generates H 2 O 2 , and (ii) Ag–Cu/CQDs catalyze the decomposition of H 2 O 2 , generating OH • , and then oxidize TMB to blue TMB ox . The established system exhibited excellent catalytic performance for detecting H 2 O 2 and GL, achieving detection limits of 0.14 and 0.06 mM, respectively, which are lower than those reported for some nanozyme‐based GL sensors. Furthermore, the developed assay successfully analyzed human urine samples, yielding recoveries ranging from 100.0% to 104.3%. Compared with natural peroxidase enzymes, Ag–Cu/CQDs have significant advantages, including simple synthesis, high stability, and cost‐effectiveness, making them promising candidates for biosensor applications.
- Open Access
- 12 August 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (8)
MIL-101 (Cr): Synthesis and simultaneous electrochemical determination of uric acid and theophylline using MIL-101 (Cr) modified electrode
This paper presents the synthesis of metal-organic frameworks in the MIL (Materials Institute Lavoisier) series using a hydrothermal process. Our research revealed that MIL-101 was formed at the early synthetic stage, approximately eight hours, followed by the formation of MIL-88B with further prolongation of the hydrothermal time. The morphology of the octahedral shape for MIL-101 transformed into the rode-like shape of MIL-88B, accompanied by a decrease in the surface area. The electrode modified by MIL-101 exhibited electrochemical activity towards uric acid and theophylline better than that modified by MIL-88B. We also developed a glassy carbon electrode (GCE) modified by MIL-101 for simultaneous uric acid and theophylline detection. Electrochemical sensing features were investigated using electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The calibration curves for uric acid and theophylline were obtained in the 0.20–1.69 µM range. The detection limits (3σ) were 0.12 µM and 0.13 µM for uric acid and theophylline, respectively. Notably, using a standard addition method, the present approach was used to determine URI and THE in urine samples, achieving exceptional recoveries. The proposed electrochemical sensor also revealed good reproducibility, repeatability, and long-term stability.
- 12 August 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (8)
Open AccessMIL-101 (Cr): Synthesis and simultaneous electrochemical determination of uric acid and theophylline using MIL-101 (Cr) modified electrode
This paper presents the synthesis of metal-organic frameworks in the MIL (Materials Institute Lavoisier) series using a hydrothermal process. Our research revealed that MIL-101 was formed at the early synthetic stage, approximately eight hours, followed by the formation of MIL-88B with further prolongation of the hydrothermal time. The morphology of the octahedral shape for MIL-101 transformed into the rode-like shape of MIL-88B, accompanied by a decrease in the surface area. The electrode modified by MIL-101 exhibited electrochemical activity towards uric acid and theophylline better than that modified by MIL-88B. We also developed a glassy carbon electrode (GCE) modified by MIL-101 for simultaneous uric acid and theophylline detection. Electrochemical sensing features were investigated using electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The calibration curves for uric acid and theophylline were obtained in the 0.20–1.69 µM range. The detection limits (3σ) were 0.12 µM and 0.13 µM for uric acid and theophylline, respectively. Notably, using a standard addition method, the present approach was used to determine URI and THE in urine samples, achieving exceptional recoveries. The proposed electrochemical sensor also revealed good reproducibility, repeatability, and long-term stability.
- Open Access
- 17 March 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (12) , 11076-11099
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer’s Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors
Searching for thiosemicarbazone derivatives with the potential to inhibit acetylcholinesterase for the treatment of Alzheimer's disease (AD) is an important current goal. The QSARKPLS, QSARANN, and QSARSVR models were constructed using binary fingerprints and physicochemical (PC) descriptors of 129 thiosemicarbazone compounds screened from a database of 3791 derivatives. The R2 and Q2 values for the QSARKPLS, QSARANN, and QSARSVR models are greater than 0.925 and 0.713 using dendritic fingerprint (DF) and PC descriptors, respectively. The in vitro pIC50 activities of four new design-oriented compounds N1, N2, N3, and N4, from the QSARKPLS model using DFs, are consistent with the experimental results and those from the QSARANN and QSARSVR models. The designed compounds N1, N2, N3, and N4 do not violate Lipinski-5 and Veber rules using the ADME and BoiLED-Egg methods. The binding energy, kcal mol-1, of the novel compounds to the 1ACJ-PDB protein receptor of the AChE enzyme was also obtained by molecular docking and dynamics simulations consistent with those predicted from the QSARANN and QSARSVR models. New compounds N1, N2, N3, and N4 were synthesized, and the experimental in vitro pIC50 activity was determined in agreement with those obtained from in silico models. The newly synthesized thiosemicarbazones N1, N2, N3, and N4 can inhibit 1ACJ-PDB, which is predicted to be able to cross the barrier. The DFT B3LYP/def-SV(P)-ECP quantization calculation method was used to calculate EHOMO and ELUMO to account for the activities of compounds N1, N2, N3, and N4. The quantum calculation results explained are consistent with those obtained in in silico models. The successful results here may contribute to the search for new drugs for the treatment of AD.
- 17 March 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (12) , 11076-11099
Open AccessNovel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer’s Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors
Searching for thiosemicarbazone derivatives with the potential to inhibit acetylcholinesterase for the treatment of Alzheimer's disease (AD) is an important current goal. The QSARKPLS, QSARANN, and QSARSVR models were constructed using binary fingerprints and physicochemical (PC) descriptors of 129 thiosemicarbazone compounds screened from a database of 3791 derivatives. The R2 and Q2 values for the QSARKPLS, QSARANN, and QSARSVR models are greater than 0.925 and 0.713 using dendritic fingerprint (DF) and PC descriptors, respectively. The in vitro pIC50 activities of four new design-oriented compounds N1, N2, N3, and N4, from the QSARKPLS model using DFs, are consistent with the experimental results and those from the QSARANN and QSARSVR models. The designed compounds N1, N2, N3, and N4 do not violate Lipinski-5 and Veber rules using the ADME and BoiLED-Egg methods. The binding energy, kcal mol-1, of the novel compounds to the 1ACJ-PDB protein receptor of the AChE enzyme was also obtained by molecular docking and dynamics simulations consistent with those predicted from the QSARANN and QSARSVR models. New compounds N1, N2, N3, and N4 were synthesized, and the experimental in vitro pIC50 activity was determined in agreement with those obtained from in silico models. The newly synthesized thiosemicarbazones N1, N2, N3, and N4 can inhibit 1ACJ-PDB, which is predicted to be able to cross the barrier. The DFT B3LYP/def-SV(P)-ECP quantization calculation method was used to calculate EHOMO and ELUMO to account for the activities of compounds N1, N2, N3, and N4. The quantum calculation results explained are consistent with those obtained in in silico models. The successful results here may contribute to the search for new drugs for the treatment of AD.